(function(){var loadHandler=window['sl_{D0ADD9BC-5BCE-4B01-85F9-188A7AEC90E6}'];loadHandler&&loadHandler(119, '<div id="spr0_aef67d0"><div id="spr1_aef67d0" class="kern slide"><img id="img1_aef67d0" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_aef67d0" class="kern slide"><div id="spr3_aef67d0" style="left:110.874px;top:175.38px;"><img id="img0_aef67d0" src="data/img144.png" width="482.25" height="327.75" alt="C:\\Users\\Alexey\\Documents\\Teaching\\LetTamAdvBC 2.jpg" style="left:0.137px;top:-0.013px;"/></div><div id="spr4_aef67d0" style="top:99.221px;"><div style="width:0px;"><span id="txt0_aef67d0" data-width="276.076172" style="left:222.485px;top:0.058px;">Advanced Breast Cancer</span></div></div><div id="spr5_aef67d0"><div style="width:0px;"><span id="txt1_aef67d0" data-width="369.236328" style="left:62.386px;top:0.058px;">Aromatase Inhibitors superiority</span></div><div style="width:0px;"><span id="txt2_aef67d0" data-width="177.365234" style="left:159.401px;top:33.658px;">over Tamoxifen</span></div></div><div id="spr6_aef67d0" style="left:220.288px;top:518.189px;"><div style="width:0px;"><span id="txt3_aef67d0" class="relpos" data-width="82.728516" style="left:7.2px;top:2.082px;">Mouridsen et al,Â </span><span id="txt4_aef67d0" class="relpos" data-width="163.541016" style="left:7.195px;top:2.082px;">J Clin Oncol, 2003, 21(11):2101-9.</span></div></div></div></div>');})();